Survey of chronic pain in Chile – prevalence and treatment, impact

Por um escritor misterioso
Last updated 03 novembro 2024
Survey of chronic pain in Chile – prevalence and treatment, impact
Background and aims The prevalence of chronic non-cancer pain has not been specifically reported in Chile. Methods In order to assess its prevalence and impact, we designed a tool based on previously published survey studies. We analyzed a sample of 784 subjects to determine the prevalence of chronic non-cancer pain, with a maximum variability of 50%, a confidence interval (CI) of 95%, and an estimation error of 3.5%. Finally, a cross-sectional cell phone survey was conducted on a nationally representative probability sample of 865 subjects of over 18 years, in November 2013. The prevalence of chronic non-cancer pain was estimated by using expansion factors according to national projections by age group and gender, from the Chilean National Institute of Statistics for the year 2010. Results The estimated prevalence of chronic non-cancer pain was 32.1% (95% CI: 26.5–36.0). The respondents with chronic non-cancer pain presented the following results: 65.7% had moderate pain, and 20.8%, severe pain; 65.6% had somatic pain, 31.7% neuropathic pain, and 2.7% visceral pain. Approximately 70% reported they were receiving some kind of pharmacological treatment with certain frequency. In 64.9%, medication was prescribed by a physician. The prevalence of sick leave in workers was 30.22%, with a median duration of 14 days (interquartile range: 14; range: 1–60). Conclusions Chronic non-oncological pain occurs in 32% of Chilean adults. These figures provide the first measurement of chronic non-cancer pain in the Chilean population. Implications Chronic non-oncological pain impact as a public health problem is revealed, given the high prevalence found, and the elevated private and social costs involved.
Survey of chronic pain in Chile – prevalence and treatment, impact
One Health for fascioliasis control in human endemic areas: Trends in Parasitology
Survey of chronic pain in Chile – prevalence and treatment, impact
Full article: The prevalence of chronic pain with an analysis of countries with a Human Development Index less than 0.9: a systematic review without meta-analysis
Survey of chronic pain in Chile – prevalence and treatment, impact
Chronic Pain Federal Health Data Trends (FULL)
Survey of chronic pain in Chile – prevalence and treatment, impact
Prevalence, burden of disease, and lost in health state utilities attributable to chronic musculoskeletal disorders and pain in Chile, BMC Public Health
Survey of chronic pain in Chile – prevalence and treatment, impact
Relationship between fatty acid intake and chronic neck/shoulder/upper limb pain without elevated CRP in a Japanese population: a cross-sectional analysis of the Shika study, Journal of Nutritional Science
Survey of chronic pain in Chile – prevalence and treatment, impact
Maximizing treatment efficacy through patient stratification in neuropathic pain trials
Survey of chronic pain in Chile – prevalence and treatment, impact
Chronic Pain Market Size, Share, Trends, Therapies and Key Players
Survey of chronic pain in Chile – prevalence and treatment, impact
Boston Scientific Launches WaveWriter Alpha™ Spinal Cord Stimulator Systems In U.S.
Survey of chronic pain in Chile – prevalence and treatment, impact
Effects of therapeutic alliance on clinical outcomes in patients with symptomatic knee osteoarthritis undergoing an exercise program: A randomized clinical trial protocol - Medwave
Survey of chronic pain in Chile – prevalence and treatment, impact
Pain Management Devices Market Growth Report
Survey of chronic pain in Chile – prevalence and treatment, impact
Short-form McGill Pain Questionnaire - Physiopedia

© 2014-2024 faktorgumruk.com. All rights reserved.